, Volume 37, Issue 2, pp 314–321 | Cite as

Interleukin 6(-174G/C) Variant and its Circulating Levels in Coronary Artery Disease Patients and Their First Degree Relatives

  • Rajesh Kumar Galimudi
  • Mrudula K. Spurthi
  • Chiranjeevi Padala
  • Kishore G. Kumar
  • Saraswati Mudigonda
  • Srilatha G. Reddy
  • Mohini T. Aiyengar
  • Sanjib K. Sahu
  • Surekha H. Rani


Interleukin-6 (IL-6) a pleiotropic cytokine is a central mediator of inflammation in the pathogenesis of coronary artery disease (CAD). Our aim is to evaluate the serum levels of IL-6 and C-reactive protein (CRP) and to analyze the IL-6 polymorphism in CAD patients and to identify the first-degree relatives (FDRs) at risk of the disease in comparison with healthy controls. Estimation of IL-6 levels by enzyme-linked immunosorbent assay (ELISA) and CRP by latex reagent kit method, and genotyping of IL6 gene variants −174 (G>C) was carried out by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in 600 subjects. IL-6 and CRP levels were significantly high in patients followed by FDRs compared to controls. The frequency of the IL-6 genotype was significantly different between cases, FDRs and controls and association of serum IL-6 levels with genotype found to be significant in CC genotype compared to GC and GG at p < 0.01 in CAD patients and FDRs, while there is no significant difference observed in controls. The study shows the importance of inflammation in the pathogenesis of CAD and predicts the risk of future coronary events in healthy asymptomatic FDRs.


coronary artery disease (CAD) interleukin-6 (IL-6) genotyping C-reactive protein (CRP) first-degree relatives (FDRs) 


  1. 1.
    Svati, H.S., J.F. Neil, Lisheng, R.C. David, H.S. David, H. Carol, J. Jessica, N. Sarah, W. Liyong, J.C. Jessica, M. Michael, S.G. Geoffrey, C.C. David, J.H.J. Christopher, V. Jeffery, H.S.J. Michael, B.G. Christopher, B.N. Christopher, G.G. Simon, J.G.C. Pascal, E.K. William, and R.H. Elizabeth. 2009. Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis. PLoS Genetics 5(1): e1000318.CrossRefGoogle Scholar
  2. 2.
    Rajeshwari, R.R., T.A. Nicklas, H.J. Pownall, and G.S. Berenson. 2005. Cardiovascular diseases—A major health risk in Asian Indians. Nutrition Research 25: 515–533.CrossRefGoogle Scholar
  3. 3.
    Apurva, S., M. Ranjit, S. Swarup, R. Rani, D. Gargi, R. Himanshu, D. Shoba, S. Aarti, D. Pradnya, T. Seema, and F.A. Tester. 2011. Prevalence of metabolic syndrome in urban India. Hindawi Publishing Corporation, Cholesterol. Volume, Article ID 920983, 7 pp.Google Scholar
  4. 4.
    Kasliwal, R.R., A. Kulshreshtha, S. Agrawal, M. Bansal, and N. Trehan. 2006. Prevalence of cardiovascular risk factors in Indian patients undergoing coronary artery bypass surgery. JAPI 54: 371–375.PubMedGoogle Scholar
  5. 5.
    Yeh, E.T.H., H.V. Anderson, V. Pasceri, and J.T. Willerson. 2001. C-reactive protein linking inflammation to cardiovascular complications. Circulation 104: 974–975.PubMedCrossRefGoogle Scholar
  6. 6.
    Ross, R. 1999. Atherosclerosis: An inflammatory disease. New England Journal of Medicine 340: 115–126.PubMedCrossRefGoogle Scholar
  7. 7.
    Sven, W., S. Michaela, S. Kerstin, S. Andreas, S. Bernhard, B. Michael, and N. Georg. 2004. Interleukin-6 induces oxidative stress and endothelial; dysfunction by overexpression of the angiotensin II type 1 receptor. Circulation Research 94: 534–541.CrossRefGoogle Scholar
  8. 8.
    Armstrong, E.J., D.A. Morrow, and M.S. Sabatine. 2006. Inflammatory biomarkers in acute coronary syndromes: Part I. Introduction and cytokines. Circulation 113: e72–e75.PubMedCrossRefGoogle Scholar
  9. 9.
    Bennermo, M., C. Held, S. Stemme, C.G. Ericsson, A. Silveira, F. Green, and P. Tornvall. 2004. Genetic predisposition of the interleukin-6 response to inflammation: Implications for a variety of major diseases? Clinical Chemistry 50(11): 2136–2140.PubMedCrossRefGoogle Scholar
  10. 10.
    Lahiri, D., and J. Nurnberger. 1991. A rapid non enzymatic method for preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Research 19: 5444.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Ross, R. 1993. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362: 802–809.CrossRefGoogle Scholar
  12. 12.
    Woods, D.J.B., S.E. Humphries, and H.E. Montgomery. 2000. Genetics of inflammation and risk of coronary artery disease: The central role of interleukin-6. European Heart Journal 21: 1574–1583.PubMedCrossRefGoogle Scholar
  13. 13.
    Connelly, J.J., T. Wang, J.E. Cox, C. Haynes, L. Wang, S.H. Shah, D.R. Crosslin, A.B. Hale, S. Nelson, D.C. Crossman, C.B. Granger, J.L. Haines, C.J.H. Jones, J.M. Vance, P.J. Goldschmidt-Clermont, W.E. Kraus, E.R. Hauser, and S.G. Gregory. 2006. GATA2 is associated with familial early-onset coronary artery disease. PLoS Genetics 2(8): e139.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Mendall, M.A., P. Patel, M. Asante, L. Ballam, J. Morris, D.P. Strachan, A.J. Camm, and T.C. Northfield. 1997. Relation of serum levels of cytokines to cardiovascular risk factors and coronary heart disease. Heart 78: 273–277.PubMedCentralPubMedGoogle Scholar
  15. 15.
    Luc, G., J.-M. Bard, I. Juhan-Vague, J. Ferrieres, A. Evans, P. Amouyel, D. Arveiler, J.-C. Fruchart, D. Ducimetiere, and on behalf of the PRIME Study Group. 2003. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease. The PRIME Study. Arteriosclerosis, Thrombosis, and Vascular Biology 23: 1255–1261.PubMedCrossRefGoogle Scholar
  16. 16.
    Humphries, S.E., L.A. Luong, M.S. Ogg, E. Hawe, and G.J. Miller. 2001. The interleukin-6–174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. European Heart Journal 22: 2243–2252.PubMedCrossRefGoogle Scholar
  17. 17.
    Ridker, P.M., J.E. Buring, J. Shih, M. Matias, and C.H. Hennekens. 1998. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98: 731–733.PubMedCrossRefGoogle Scholar
  18. 18.
    Bo, I.M., A.S. Raspo, E. Morra, G. Isaia, M. Cassader, E. Fabris, and L. Poli. 2004. Body fat and C-reactive protein levels in healthy non-obese men. Nutrition, Metabolism, and Cardiovascular Diseases 14: 66–72.PubMedCrossRefGoogle Scholar
  19. 19.
    Koenig, W., M. Sund, M. Frohlich, H.G. Fischer, H. Lowe, A. Doring, W.L. Hutchinson, and M.B. Pepys. 1999. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99: 237–242.PubMedCrossRefGoogle Scholar
  20. 20.
    Yudkin, J.S., C.D.A. Stehouwer, J.J. Emeis, and S.W. Coppack. 1999. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction a potential role for cytokines originating from adipose tissue? Arteriosclerosis, Thrombosis, and Vascular Biology 19: 972–978.PubMedCrossRefGoogle Scholar
  21. 21.
    Josemanuel, F.R., V. Montserrat, R. Cristobal, G. Cristina, B. Montserrat, V. Joan, and R. Wifredo. 2001. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. Journal of Clinical Endocrinology and Metabolism 86: 1154–1159.CrossRefGoogle Scholar
  22. 22.
    Dimitris, A.P., L.W. Ronald, C.M. Stavros, and P.C. George. 1998. The pathophysiologic roles of interleukin-6 in human disease. Annals of Internal Medicine 128: 127–137.CrossRefGoogle Scholar
  23. 23.
    Aukrust, P., T. Ueland, E. Lien, et al. 1999. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. American Journal of Cardiology 83: 376–382.PubMedCrossRefGoogle Scholar
  24. 24.
    Liu, Y., S.Y. Berthier, M.D. Fallin, N.E. Fink, R.P. Tracy, and M.J. Klag. 2006. IL-6 Haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort. Journal of the American Society of Nephrology 17: 863–870.PubMedCrossRefGoogle Scholar
  25. 25.
    Danesh, J., K. Stephen, G.M. Andrea, S. Nadeem, W. Angela, B.A. Sara, W. Frances, P.T.H. Julian, L. Lucy, E. Gudny, R. Ann, H.W. Peter, D.O.L. Gordon, and G. Vilmundur. 2008. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review. PLoS Medicine 5(4): e78.PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Ridker, P.R., R. Nader, J.S. Meir, and H.H. Charles. 2000. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men; atherogenesis. Circulation 101: 1767–1772.PubMedCrossRefGoogle Scholar
  27. 27.
    Mohlig, M., B. Heiner, S. Joachim, O. Martin, K. Anja, E.V.A. Fisher, M.B. Manuela, R. Michael, H. Kurt, and F.H.P. Andreas. 2004. Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 89: 1885–1890.PubMedCrossRefGoogle Scholar
  28. 28.
    Jones, K.G., D.J. Brull, M. Sian, L.C. Brown, S.E. Humphries, and J.T. Powell. 2001. Interleukin-6 and the prognosis of abdominal aortic aneurysm. Circulation 103: 2260–2265.PubMedCrossRefGoogle Scholar
  29. 29.
    Georges, J.L., V. Loukaci, O. Poirier, A. Evans, G. Luc, D. Arveiler, J.B. Ruidavets, F. Cambien, and L. Tiret. 2001. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: The ECTIM study. Journal of Molecular Medicine 79: 300–305.PubMedCrossRefGoogle Scholar
  30. 30.
    Terry, C.F., V. Loukaci, and F.R. Green. 2000. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. Journal of Biological Chemistry 275: 18138–18144.PubMedCrossRefGoogle Scholar
  31. 31.
    Fishman, D., G. Faulds, R. Jeffery, V. Mohamed-Ali, J.S. Yudkin, S. Humphries, et al. 1998. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. Journal of Clinical Investigation 102: 1369–1376.PubMedCentralPubMedCrossRefGoogle Scholar
  32. 32.
    Roger, R.W., C.H. Steven, H. Gerardo, A.P. Michael, T.B. Jeannette, H. Millicent, M.C. Robert, W. Joan, and N.H. Paul. 2001. Usefulness of cardiovascular family history data for population-based preventive medicine and medical research. (The Health Family Tree Study and the NHLBI Family Heart Study). American Journal of Cardiology 87: 129–135.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Rajesh Kumar Galimudi
    • 1
  • Mrudula K. Spurthi
    • 1
  • Chiranjeevi Padala
    • 1
  • Kishore G. Kumar
    • 1
  • Saraswati Mudigonda
    • 1
  • Srilatha G. Reddy
    • 1
  • Mohini T. Aiyengar
    • 1
  • Sanjib K. Sahu
    • 2
  • Surekha H. Rani
    • 1
  1. 1.Department of GeneticsOsmania UniversityHyderabadIndia
  2. 2.Durgabai Deshmukh Hospital and Research CenterHyderabadIndia

Personalised recommendations